These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 7813544

  • 21. Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo.
    Rampart M, Williams TJ.
    Br J Pharmacol; 1988 Aug; 94(4):1143-8. PubMed ID: 2850056
    [Abstract] [Full Text] [Related]

  • 22. Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans.
    Kanamori Y, Niwa M, Kohno K, Al-Essa LY, Matsuno H, Kozawa O, Uematsu T.
    Life Sci; 1997 Aug; 60(16):1407-17. PubMed ID: 9096262
    [Abstract] [Full Text] [Related]

  • 23. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
    Wang JP, Chang LC, Lin YL, Hsu MF, Chang CY, Huang LJ, Kuo SC.
    Biochem Pharmacol; 2003 Apr 01; 65(7):1043-51. PubMed ID: 12663040
    [Abstract] [Full Text] [Related]

  • 24. NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction.
    Smith RJ, Justen JM, Bleasdale JE, Sly LM.
    Br J Pharmacol; 1995 Apr 01; 114(8):1694-702. PubMed ID: 7599938
    [Abstract] [Full Text] [Related]

  • 25. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.
    Suda T, Suzuki Y, Matsui T, Inoue T, Niide O, Yoshimaru T, Suzuki H, Ra C, Ochiai T.
    Br J Dermatol; 2005 May 01; 152(5):887-95. PubMed ID: 15888142
    [Abstract] [Full Text] [Related]

  • 26. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
    Gryglewski RJ, Szczeklik A, Wandzilak M.
    Biochem Pharmacol; 1987 Dec 15; 36(24):4209-13. PubMed ID: 2446631
    [Abstract] [Full Text] [Related]

  • 27. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production.
    Gyllenhammar H.
    J Immunol Methods; 1987 Mar 12; 97(2):209-13. PubMed ID: 3029229
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr 12; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 29. The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol.
    Kitsis EA, Weissmann G, Abramson SB.
    J Rheumatol; 1991 Oct 12; 18(10):1461-5. PubMed ID: 1662723
    [Abstract] [Full Text] [Related]

  • 30. Characterization of the inhibitory prostanoid receptors on human neutrophils.
    Wheeldon A, Vardey CJ.
    Br J Pharmacol; 1993 Apr 12; 108(4):1051-4. PubMed ID: 8387383
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of propranolol on responses to receptor-dependent and receptor-independent stimuli in human neutrophils.
    Gay JC, Murray JJ.
    Biochim Biophys Acta; 1991 Nov 12; 1095(3):236-42. PubMed ID: 1659906
    [Abstract] [Full Text] [Related]

  • 32. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
    Ozaki Y, Ohashi T, Niwa Y.
    Biochem Pharmacol; 1986 Oct 15; 35(20):3481-8. PubMed ID: 3021173
    [Abstract] [Full Text] [Related]

  • 33. Selective inhibition of protein kinase C, mitogen-activated protein kinase, and neutrophil activation in response to calcium pyrophosphate dihydrate crystals, formyl-methionyl-leucyl-phenylalanine, and phorbol ester by O-(chloroacetyl-carbamoyl) fumagillol (AGM-1470; TNP-470).
    Tudan C, Jackson JK, Pelech SL, Attardo G, Burt H.
    Biochem Pharmacol; 1999 Dec 15; 58(12):1869-80. PubMed ID: 10591141
    [Abstract] [Full Text] [Related]

  • 34. B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjects.
    Liu S, Ngo DT, Stewart S, Horowitz JD, Chirkov YY.
    Clin Exp Pharmacol Physiol; 2014 Oct 15; 41(10):739-43. PubMed ID: 25115801
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S.
    Br J Pharmacol; 1994 Oct 15; 113(2):513-21. PubMed ID: 7834203
    [Abstract] [Full Text] [Related]

  • 36. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
    Feltner DE, Smith RH, Marasco WA.
    J Immunol; 1986 Sep 15; 137(6):1961-70. PubMed ID: 3018082
    [Abstract] [Full Text] [Related]

  • 37. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM.
    J Pharmacol Exp Ther; 1992 Dec 15; 263(3):1009-14. PubMed ID: 1335049
    [Abstract] [Full Text] [Related]

  • 38. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
    Angle MJ, McManus LM, Pinckard RN.
    Lab Invest; 1986 Dec 15; 55(6):616-21. PubMed ID: 3465972
    [Abstract] [Full Text] [Related]

  • 39. Prostaglandin D2 modulates human neutrophil intracellular calcium flux and inhibits superoxide release via its ring carbonyl.
    Simpkins CO, Mazorow DL, Alailima ST, Tate EA, Sweatt W, Johnson M, Shariff K, Millar DB.
    Life Sci; 1990 Dec 15; 46(11):793-801. PubMed ID: 2319907
    [Abstract] [Full Text] [Related]

  • 40. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M.
    J Pharmacol Exp Ther; 2001 Apr 15; 297(1):388-94. PubMed ID: 11259567
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.